Evercyte GmbH

👀 Check out our new range of 𝘁𝗲𝗹𝗼𝗺𝗲𝗿𝗶𝘇𝗲𝗱 𝗽𝗲𝗿𝗶𝗻𝗮𝘁𝗮𝗹 𝗰𝗲𝗹𝗹𝘀 that can be grown without limitations in vitro, while preserving cell type-specific markers and functions. These cells are derived from different regions of the placenta and offer standardizable models for critical research areas such as placental barrier function and toxicity assays.  Our MSC cells grown under xeno-free conditions with full-documentation and can also be transferred to GMP facilities to produce clinical-grade extracellular vesicles (EVs). Our perinatal cells include: • P-EP/SVTERT344 - 𝗔𝗺𝗻𝗶𝗼𝘁𝗶𝗰 𝗘𝗽𝗶𝘁𝗵𝗲𝗹𝗶𝗮𝗹 𝗖𝗲𝗹𝗹𝘀 https://lnkd.in/dCAVtEvd • P-MSC/TERT308 - 𝗣𝗹𝗮𝗰𝗲𝗻𝘁𝗮𝗹 𝗔𝗺𝗻𝗶𝗼𝗻 𝗠𝗦𝗖𝘀 https://lnkd.in/dERRhnWQ • CP-MSC/TERT308 - 𝗣𝗹𝗮𝗰𝗲𝗻𝘁𝗮𝗹 𝗖𝗵𝗼𝗿𝗶𝗼𝗻𝗶𝗰 𝗣𝗹𝗮𝘁𝗲 𝗠𝗦𝗖𝘀 https://lnkd.in/dtn-v9SQ  • RA-MSC/TERT308 - 𝗥𝗲𝗳𝗹𝗲𝗰𝘁𝗲𝗱 𝗔𝗺𝗻𝗶𝗼𝗻 𝗠𝗦𝗖𝘀 https://lnkd.in/dsMNnVVa By leveraging telomerized cells, Evercyte continues to overcome the limitations of normal primary and tumor cells, delivering long-term growth potential while maintaining essential cell characteristics.   Read the PR ➡️ https://lnkd.in/dC-Ek8Ad #Evercyte #TelomerizedCells #PerinatalCells #MSC #EVs

Now that the #ASEVCzeSEV2024 conference has officially ended, ASEV and CZESEV would like to thank our sponsors! Without them, this event wouldn’t have been possible. A big thank you to our PLATINUM sponsors Beckman Coulter Life Sciences and EVscale (Evercyte GmbH, Phoenestra GmbH, TAmiRNA GmbH) for their support, and for attending despite the heavy rain and flooding in Vienna and across Europe. Thank you all for your excellent presentations on new devices that will help advance EV research!

🥁 The #ASEVCzeSEV2024 meeting is about to start! Our team is very exited to participate and delve into the latest discoveries in the EV field. 🗣If you see one of our team members, strike up a conversation! 🤝 You are welcome to visit our booth to learn more about our work and explore potential synergies. #Evercyte #ASEVCzeSEV2024 #ExtracellularVesicles #EVscale™️ #meettheteam

🤩 Looking forward to meeting you all at the #ASEVCzeSEV meeting next week and sharing more about #EVscale™. Visit our booth and attend our presentation (Afternoon Session 2: News from Industry) to know how we can help you in advancing scalable EV manufacturing! #ASEVCzeSEV2024 #Evercyte #TAmiRNA #Phoenestra #EVscale™️ #ExtracellularVesicles

📣 New review article from the LifeSaver Project Consortium on fetal-maternal interactions, focusing on the placenta's role in the first trimester.🤰 Glad to be part of this Consortium and contributing with our telomerized perinatal cell lines to study drug transport from mother to child. Thanks to our partners and collaborators for their support. #Evercyte #LifeSaverProject #PerinatalCells #PlacentaResearch

Great output of the MSCA-ITN #in3! Using a single iPSC line differentiiated into all tissue types allowing for comparative toxicology. Congrats to all the in3 partners!

🔬iPSC differentiated cells as models model systems for in vitro toxicology   We're excited to share the findings from our recent study on the differentiation of human induced pluripotent stem cells (iPSCs) into various toxicologically relevant cell types. iPSCs hold immense potential for generating specific cell types in vitro, enabling high-throughput screening for drugs and chemicals, significantly reducing the costs of drug discovery and minimizing post-clinical trial withdrawals.   In this research, conducted within the in3 consortium, we used iPSC lines to differentiate into several target cell types, including alveolar macrophages, brain cells, hepatocytes, monocytes and more. At Evercyte, we specifically contributed by differentiating these iPSCs into endothelial cells. Using targeted transcriptomics, we successfully characterized these differentiated cells, demonstrating distinct separation from undifferentiated iPSCs.   These findings confirm that iPSC-derived cell types can be reliable and standardizable models for in vitro toxicology, paving the way for more effective and cost-efficient drug testing.   Kudos to the entire team for this remarkable achievement, and special recognition to our then-PhD student, Zahra Mazidi, who conducted the work! Read the full article here ➡️https://lnkd.in/dq_293n6 #Evercyte #iPSC #EndothelialCells #in3 

🎉 We are happy to announce that we have partnered with the new distributor Chameleon Science to bring our products to even more customers! This new collaboration marks a significant milestone in our growth journey, and we couldn’t be more excited about the opportunities it presents.   Together, we will be able to expand our reach and provide our products to a wider audience, ensuring that more people can experience the value we deliver.   📨 If you want to become our distributor drop us an email at office@evercyte.com #Evercyte #EVs #telomerizedcells

🚀 Exciting News! 🚀 🎉 We are thrilled to announce the newest addition to our Cell Family Wall: 𝗜𝗺𝗺𝗼𝗿𝘁𝗮𝗹𝗶𝘇𝗲𝗱 𝗛𝘂𝗺𝗮𝗻 𝗔𝗺𝗻𝗶𝗼𝘁𝗶𝗰 𝗘𝗽𝗶𝘁𝗵𝗲𝗹𝗶𝗮𝗹 𝗖𝗲𝗹𝗹𝘀!   Just like hanging a cherished photo to our wall at home, unveiling a new cell line is a moment of pride and excitement. This new member of our cell family represents countless hours of dedication, innovation, and teamwork. We can't wait to see the incredible discoveries and breakthroughs it will contribute to! 💡 𝗞𝗲𝘆 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀: • 𝗘𝘅𝘁𝗲𝗻𝗱𝗲𝗱 𝗟𝗶𝗳𝗲𝘀𝗽𝗮𝗻: Enhanced cell longevity to support long-term research projects • 𝗖𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝘁 𝗣𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲: Reliable and reproducible results for your critical experiments • 𝗩𝗲𝗿𝘀𝗮𝘁𝗶𝗹𝗲: Ideal for a wide range of applications including the establishment of in vitro models to study e.g. the barrier function of the placenta and perform toxicity studies A huge thank you to our dedicated team and partners for making this vision a reality.   #Evercyte #immortalizedcells #telomerizedcells #amnionepithelialcells #NewProductRelease Check out our newly released cells ➡ https://lnkd.in/dCAVtEvd Read the PR 📑https://lnkd.in/dVdaBBsH   #Evercyte #immortalizedcells #telomerizedcells #amnioticepithelialcells #NewProductRelease

📣 Thrilled to announce that our project was featured in the ChemieReport magazine! In collaboration with VetMedUni and partners within the Viennese LifeSciences ecosystem, our research project has focused on identifying active substances in the secretome of various fetal cells that could promote tissue regeneration, reduce inflammation, and rejuvenate articular cartilage in the context of osteoarthritis.   ⬇ Check out the article to learn more about the project! https://lnkd.in/dCTgRG77   #Evercyte #Osteoarthritis #RegenerativeMedicine #TissueRegeneration #MesenchymalStromalCells #ExtracellularVesicles